The Effects of Expressive Writing and Compassionate Letter Writing on Emotional Distress Intolerance
Launched by UNIVERSITY OF WATERLOO · Mar 16, 2022
Trial Information
Current as of October 03, 2025
Completed
Keywords
ClinConnect Summary
The study consisted of two online surveys. During the first survey, participants answered a set of questionnaires. Then, they were prompted to think of an upsetting situation and the associated unpleasant emotions, and they were then randomly assigned to a brief self-compassionate writing, expressive writing, or neutral writing task. They then answered a series of questionnaires immediately after completing the writing task. During the second survey, one week later, participants answered a brief set of questionnaires.
Gender
ALL
Eligibility criteria
- Inclusion Criteria for University of Waterloo sample:
- • Undergraduate students with a SONA account who are high in emotional distress intolerance (i.e. a lower-than-average score on the Distress Tolerance Scale; mean based on SONA student sample)
- Inclusion Criteria for Prolific sample:
- • Adults with a Prolific account who are high in emotional distress intolerance (i.e. a lower-than-average score on the Distress Tolerance Scale; mean based on Prolific sample)
- • First language English speakers
- Exclusion Criteria:
- • None
About University Of Waterloo
The University of Waterloo is a leading research institution located in Ontario, Canada, known for its innovative approach to education and commitment to advancing knowledge across various disciplines. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to translate research findings into practical applications for health and wellness. Leveraging cutting-edge technology and a robust network of academic and industry partnerships, the University of Waterloo is dedicated to improving patient outcomes and fostering advancements in healthcare through rigorous scientific inquiry and ethical clinical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Waterloo, Ontario, Canada
Patients applied
Trial Officials
Allison Kelly, PhD
Principal Investigator
Associate professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials